Ribociclib and Aromatase Inhibitor in Treating Older Participants With Hormone Receptor Positive Metastatic Breast Cancer
Part of paid clinical trials in Corona, California.
- Sponsor
- City of Hope Medical Center
- Study ID
- NCT03477396
- Phase
- PHASE2
- Status
- Completed
Conditions
- Estrogen Receptor and/or Progesterone Receptor Positive
- HER2/Neu Negative
- Stage IV Breast Cancer AJCC v6 and v7
Eligibility Criteria
- Sex
- ALL
- Age
- 70 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Aromatase Inhibitor — DRUGAromatase inhibitor per treating investigator's discretion
- Laboratory Biomarker Analysis — OTHERCorrelative studies
- Pharmacokinetic Study — OTHERCorrelative studies
- Questionnaire Administration — OTHERAncillary studies
- Ribociclib — DRUGGiven PO
Study Details
This phase IIA trial studies the side effects of ribociclib and aromatase inhibitor and how well they work in treating participants with hormone receptor positive breast cancer that has spread to other places in the body. Ribociclib and aromatase inhibitors may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Key Dates
- Start date
- Jun 14, 2018
- Status verified
- Feb 2024
- Primary completion
- Sep 29, 2021
- Completion
- Jun 5, 2023
Study Design
- Enrollment
- 2 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Treatment (ribociclib, aromatase inhibitor)Participants receive ribociclib orally PO QD on days 1-21 and aromatase inhibitor per treating investigator's discretion. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Primary Outcome Measure
Number of Participants With Grade 2 and Above Toxicities Attributed to Ribociclib [ Time Frame: Up to 30 days of last study drug, about 3 years and 3 months ]
Locations (9)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| City of Hope Corona | Corona | California | 92879 | - |
| City of Hope Medical Center | Duarte | California | 91010 | - |
| City of Hope Antelope Valley | Lancaster | California | 93534 | - |
| City of Hope Mission Hills | Mission Hills | California | 91345 | - |
| City of Hope Rancho Cucamonga | Rancho Cucamonga | California | 91730 | - |
| City of Hope South Pasadena | South Pasadena | California | 91030 | - |
| City of Hope West Covina | West Covina | California | 91790 | - |
| Roswell Park Cancer Institute | Buffalo | New York | 14263 | - |
| Wilmot Cancer Institute | Rochester | New York | 14642 | - |
Find similar trials in Corona, CA
Related Studies
- S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac ToxicityPHASE3 · Recruiting · SWOG Cancer Research Network · Anchorage, Alaska
- S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast CancerRecruiting · SWOG Cancer Research Network · Anchorage, Alaska
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionRecruiting · Alliance for Clinical Trials in Oncology · Anchorage, Alaska
- Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic TherapyRecruiting · M.D. Anderson Cancer Center · Gilbert, Arizona